Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nustay hits all-time high sales record

Today, Nustay A/S (“Nustay”) announces that on Saturday December 21st the company hit an all-time high sales record with the highest number of bookings and handled revenue that Nustay has had in a single day since the platform was launched. A total of 751 hotel bookings was successfully completed on the platform during the 24-hour period, resulting in a total handled revenue of more than 681,000 DKK.Mathias Lundoe Nielsen, CEO, comments “We are of course extremely happy to announce this sales record and we are proud that we are able to achieve such high sales numbers in the end of

TietoEVRY’s Board of Directors resolves on incentive plans for key employees

TietoEVRY Corporation   STOCK EXCHANGE RELEASE  23 December 2019 11.00 am EETTietoEVRY’s Board of Directors resolves on incentive plans for key employeesTietoEVRY’s Board of Directors has approved two new share-based incentive plans for key employees of TietoEVRY and its subsidiaries, a Performance Share Plan 2020–2022 and a Restricted Share Plan 2020–2022. The aim of the plans is to align the objectives of shareholders and key employees in order to increase the value of the company in the long term. TietoEVRY will nominate approximately 350 key employees, including TietoEVRY’s Group

Castellum signs off on the Säve Airport acquisition – boosts development pace at the leading Nordic hub for logistics, sustainable transport and mobility

Castellum and Serneke have agreed that Castellum will sign off on its commitment to an additional consideration for Säve Airport through an advance lump-sum payment of approx. MSEK 300, after deduction for deferred tax of approx. MSEK 60. The advance sum contrasts well to the maximum possible additional consideration, set at SEK 1,3 billion at the time of acquisition. In the process, Castellum will also reap significant time efficiencies in the company’s efforts to develop one of the largest, most modern and most innovative Nordic logistics hubs. The move also provides Castellum with

Stockmann’s financial reports in 2020

STOCKMANN plc, Financial calendar 23.12.2019 at 11:00 EET Stockmann will publish its financial statements bulletin for 2019 on 13 February 2020. The company’s financial statements and an electronic version of the Annual Report will be published in the week starting on 24 February 2020. The Annual General Meeting is planned to be held on 18 March 2020. The Interim Reports will be released in 2020 as follows:- Interim Report, January-March: 30 April 2020- Half year financial report, January-June: 24 July 2020- Interim Report, January-September: 30 October 2020 The financial

LKAB increases its shareholding in SSAB

LKAB has today made a notification of an increased shareholding in SSAB, which now corresponds to 5,1 percent of the shares and votes.LKAB and SSAB have an extensive business relationship and joint collaborative projects such as HYBRIT. HYBRIT is an initiative between LKAB, SSAB and Vattenfall with the purpose to create an entirely fossil-free process for steelmaking – from mining to finished steel. A pilot plant will open in Luleå during the third quarter of 2020. LKAB is hence well acquainted with SSAB and has been a shareholder since SSAB's shares were listed on the stock market in 1989.

Nustay enters new partnership agreement with Europlayas

Nustay A/S (“Nustay”) has today announced a new distribution agreement with Europlayas. Based in Spain, Europlayas is a leading online hotel supplier specialising in the Mediterranean region and offers an extensive inventory of over 120,000 hotels.New partnership Nustay has entered a distribution partnership agreement with Europlayas, which will give Nustay access to a hotel inventory of over 120,000 hotels. Europlayas is a leading online hotel supplier based in Spain, that maintains key direct hotel contracts in Malta, Greece, Portugal, Italy, Andorra, Albania and Spain. With over 40

Invitation to SCA’s Q4 2019 press conference

The press conference held in connection with the publication of SCA’s interim report for the fourth quarter of 2019, will also be available via webcast or by phone.The interim report will be published on January 30, 2020, at approximately 08:00 CET. The subsequent press conference will be held at 10:00 CET at the conference room Sankta Clara, Kapitel 8 Klara Strand, Klarabergsviadukten 90 in Stockholm, Sweden. At the press conference, President and CEO Ulf Larsson and CFO Toby Lawton will present and answer questions regarding the report. Press conference:Date: Thursday January 30,

Metsä Tissue has agreed to divest its napkin business to Mutares Group

Metsä Tissue press release 23 December 2019Metsä Tissue, part of Metsä Group, has agreed to divest its napkin business to keeeper Group, which is part of Mutares Group. The transaction includes the real estate, machinery and equipment and warehouses at the Stotzheim mill in Germany as well as the Fasana and Mondial brands. As a result of the transaction, the mill’s personnel is planned to be transferred to the new owner as existing employees. “The napkin business has not reached profitability targets lately and napkins are not part of our core offering anymore. Thus we have explored all

Skanska upgrades Junction 6 of the M42 in Birmingham, UK, for about GBP 143 M, about SEK 1.7 billion

Skanska has signed a contract with Highways England for the upgrade of Junction 6 of the M42 highway in Birmingham, UK. The contract is worth GBP 143 M, about SEK 1.7 billion, which will be included in the order bookings for Europe for the fourth quarter 2019.The project near Birmingham Airport is part of the M42 improvement scheme, a major highways project and an important part of the UK strategic road network. The project team will take the scheme from preliminary design stage through to handover. Construction will start in 2020 and the project will run for five years. Skanska is

Metsä Tissue has agreed to divest its napkin business to Mutares Group

Metsä Group press release 23 December 2019Metsä Tissue, part of Metsä Group, has agreed to divest its napkin business to keeeper Group, which is part of Mutares Group. The transaction includes the real estate, machinery and equipment and warehouses at the Stotzheim mill in Germany as well as the Fasana and Mondial brands. As a result of the transaction, the mill’s personnel is planned to be transferred to the new owner as existing employees. “The napkin business has not reached profitability targets lately and napkins are not part of our core offering anymore. Thus we have explored all

TargetEveryone’s associated company in Norway, Cloud Explorers, signs new contract with PostNord

TargetEveryone’s associated company in Norway, Cloud Explorers, signs a new contract with PostNord as a customer. PostNord offers communications and logistics solutions to, from and within the Nordic region. In 2018, PostNord delivered 3.3 billion letters and shipments, 171 million parcels to the Nordic region’s 27 million residents and two million businesses. PostNord is owned 40% by the Danish State and 60% by the Swedish State.   TargetEveryone has an ownership of 30 % in Cloud Explorers and is also the exclusive tech partner to TargetEveryone in the development of SpectrumOne.

Carbiotix signs collaboration agreement with academic partner focused on neuroinflammation

Carbiotix (publ) ("Carbiotix") announces today that the company has signed a collaboration agreement with the Department of Medicine at the University of Verona, Italy, to carry out a research study during H1 2020 in the area of neuroinflammation using Carbiotix Microbiome Modulator Therapeutics. The collaboration agreement will seek to find new applications and further validate Carbiotix platform.The in-vivo research study to be conducted in H1 2020 will be led by Dr. Elena Zenaro, a researcher at the Department of Medicine, General Pathology Section, at the University of Verona, Italy.

Scandion Oncology obtains approval from the Ethics Committee on Clinical Application for SCO-101 in patients with drug-resistant metastatic colorectal cancer

Scandion Oncology A/S ("Scandion Oncology") today announces that the company has received approval from the Ethics Committee regarding its first clinical trial for SCO-101 at hospitals in Denmark. The only change that the Ethics Committee requested was to include a one-page summary of the patient information sheet for review before the study could be started.  With this approval, Scandion Oncology follows its objectives.Clinical Phase II trial with SCO-101 in patients with drug-resistant metastatic colorectal cancer Scandion Oncology’s first clinical Phase II study with SCO-101 targeting

Information about the AGM and appointed Nomination Committee in K-Fast Holding AB

The Annual General Meeting (“AGM”) in K-Fast Holding AB will be held on Tuesday 19 May 2020, at 5 p.m. CET. Venue: Hotel Statt, Frykholmsgatan 13 in Hässleholm, Sweden.Shareholders who wish to have a matter dealt with at the AGM shall, in order for the request to be taken into consideration, submit such proposal to the Board latest by 31 March 2020. The Board can be contacted through the Secretary of the Board at e-mail: ck@vici.se or by regular mail: K-Fastigheter, Nomination Committee, Bultvägen 7, SE-281 42, Hässleholm, Sweden. According to the instructions for the Nomination

Karolinska University Hospital part of the first kidney transplant program across Scandinavia – Scandia Transplant Kidney Exchange Program (STEP)

For the first time two kidney replacements have been performed involving donors and transplant patients who are part of the Scandinavian kidney exchange program STEP organized by Scandiatransplant.  The organization coordinates organ donations and transplants in Denmark, Estonia, Finland, Iceland, Norway and Sweden. During 2018 and 2019 Karolinska University Hospital performed and coordinated three STEP exchange programs with a total of six couples in cooperation with other hospitals in Sweden.- The number of patients waiting for a new kidney in Sweden increased by more than 10% from 2018

TietoEVRY: Holding of Apax Guernsey (Holdco) PCC Limited below 20%

TietoEVRY Corporation STOCK EXCHANGE RELEASE 23 December 2019 9.30 am EETTietoEVRY: Holding of Apax Guernsey (Holdco) PCC Limited below 20% TietoEVRY Corporation has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Apax Guernsey (Holdco) PCC Limited. The holding of Apax Guernsey (Holdco) PCC Limited has fallen below the 20% threshold on 20 December. The holding of Lyngen Holdco S.à r.l., a company ultimately controlled by Apax Guernsey (Holdco) PCC Limited, amounts to 19 872 767 shares, representing 16.78% of the shares and

SpareBank 1 SR-Bank ASA (SRBANK); CORRECTION - Decision of MREL requirement has been made public

SpareBank 1 SR-Bank ASA has received its MREL requirement from the Norwegian Financial Supervisory Authority. According to the notice, SpareBank SR-Bank shall hold total MREL capital equal to 32.9 per cent of adjusted Risk Weighted Assets. The requirement is based on the bank’s balance as of 31 December 2018. This leads to a requirement of eligible liabilities of NOK 33 714 million. The MREL requirement, according to the notice, is applicable from 31 March 2020. The requirement for eligible liabilities is applicable from 31 December 2022. Senior preferred debt, with remaining maturity

Board members and management in Initiator Pharma exercise warrants

Initiator Pharma A/S (INIT) today announces that individuals in the board and managemet exercise a total of 434 197 warrants for subscription of new shares, raising approx 1,9 SEKM in proceeds to the company. The number of issued shares increases by 434 197 and the share capital increases by 45 590,685 DKK.The warrants have been exercised under the warrant program 2017/2020, approved by the Annual General Meeting of 16 May 2017, comprising 434,197 warrants and has been fully exercised according to the below distribution: [][][][]Individual[1] Position Excercised Share holding

MREL requirement

Further to today’s announcement from the Norwegian Financial Supervisory Authority (the “FSA”), DNB ASA has received minimum requirement for own funds and eligible liabilities (the “MREL requirement”). DNB ASA shall hold total MREL capital equal to 36.7 percent of its adjusted risk weighted assets based on the balance per 31 December 2018, which leads to a need for eligible debt of NOK 157 billion. This is in line with the previously communicated expectation of approximately NOK 150 billion. The MREL requirement will vary over time based on changes in risk weighted assets and capital

Axel Johnson International extends its offering in power transmission solutions in Slovenia

Axel Johnson International’s business group Power Transmission Solutions has acquired Bell d.o.o., effective 19 December 2019. Bell is a leading Slovenian provider of power transmission products and services since more than 30 years.“Entering the Slovenian market by the acquisition of Bell is well in line with our business group strategy for expanded geographical presence and further strengthened market offering in services and technical expertise. The Slovenian market offers many structural advantages for the power transmission industry, which caters for good long-term growth prospects”,

The pivotal Phase 3 clinical trial NefIgArd Part A fully recruited

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced the full recruitment of all 200 patients required for Part A of the company’s pivotal Phase 3 study NefIgArd. Top line readout of Part A of the study is expected in Q4 2020.The study will continue to recruit an additional 160 patients during 2020 in order to complete Part B of the trial. The NefIgArd trial is studying the effect of Nefecon versus placebo on proteinuria in patients with IgA nephropathy (IgAN) at approximately 140 sites in 19 countries.  The first patient was randomized in November 2018. On the basis of

Enhertu (trastuzumab deruxtecan) approved in US

23 December 2019 07:00 GMT Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prioranti-HER2 based regimens Accelerated Approval of AstraZeneca and Daiichi Sankyo's Enhertu based on the DESTINY-Breast01 trial that showed clinically meaningful and durable responses AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or

Triple-combination approved in China for COPD

23 December 2019 07:00 GMT AstraZeneca's triple-combination therapyapproved in China for patients with COPD First fixed-dose triple-combination therapy in apressurised metered-dose inhaler device in China Budesonide/glycopyrronium/formoterol fumarate is known asPT010 outside of China and as Breztri Aerosphere in Japan AstraZeneca today announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This is the first approval by the National Medical Products

There are no items matching the current filter
There are no more items matching the current filter
Back to top